BRILLIANCE Trial

Oregon Health & Science University provides a curated selection of high-resolution photos, video footage, b-roll and graphics for news organizations and media coverage related to OHSU stories. Commercial use is prohibited without prior written consent.

Media usage guidelines

  • Photos and video should be credited as “OHSU/Photographer name.”
  • Metadata includes captions and usage restrictions.
  • Color correction and cropping are allowed. The content or nature of the photo may not be altered.

Questions or requests: Please contact OHSU Strategic Communications at news@ohsu.edu or 503-494-8231.

BRILLIANCE trial
BRILLIANCE trial

Carlene Knight sits outside OHSU’s Casey Eye Institute on April 29, 2021. Knight, who has a genetic form of inherited vision loss, is participating in the BRILLIANCE clinical trial testing an investigational gene-editing treatment designed to repair the mutation and improve vision. (OHSU/Josh Andersen)

BRILLIANCE trial 2
BRILLIANCE trial 2

Carlene Knight sits outside OHSU’s Casey Eye Institute on April 29, 2021. Knight, who has a genetic form of inherited vision loss, is participating in the BRILLIANCE clinical trial testing an investigational gene-editing treatment designed to repair the mutation and improve vision. (OHSU/Josh Andersen)

BRILLIANCE trial 3
BRILLIANCE trial 3

A clinician examines Carlene Knight’s eyes at OHSU’s Casey Eye Institute as part of the BRILLIANCE clinical trial, which is testing an investigational gene-editing treatment for inherited vision loss. (OHSU/Josh Andersen)

BRILLIANCE trial 4
BRILLIANCE trial 4

A clinician examines Carlene Knight’s eyes at OHSU’s Casey Eye Institute as part of the BRILLIANCE clinical trial, which is testing an investigational gene-editing treatment for inherited vision loss. (OHSU/Josh Andersen)